Company plans to stop selling the product globally this year
In subgroup analyses, lower risk was seen with cumulative dosage of ≥401 mg or with therapy duration of five years or longer
At three, six, and nine years, overall survival was 64, 43, and 26 percent and progression-free survival was 88, 78, and 78 percent, respectively
Eight of nine patients with major pathological response (MPR) were alive and disease-free at five years, while six of 11 without MPR experienced relapse
Improvement observed in detection of actionable lung nodules with no increase in false-referral rates
Sublobar resection is noninferior for disease-free and overall survival for patients with tumors ≤2 cm
Risk model-based lung cancer screening strategy more cost-effective than 2021 USPSTF recommendations
Despite NCCN guidelines recommending FDG PET/CT, 43.6 percent of patients were imaged with CT alone before subsequent radiation therapy
Sybil achieved areas under receiver operating characteristic curve of 0.92, 0.86, and 0.94 on three external validation sets
Shape-sensing robotic-assisted bronchoscopy with imaging has high diagnostic accuracy, sensitivity, specificity